Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States

Regional and racial variations in the utilization of endoscopic retrograde cholangiopancreatography among pancreatic cancer patients in the United States

Abstract Background Pancreatic cancer is projected to become the second leading cause of cancer‐related deaths by 2030. Endoscopic retrograde cholangiopancreatography (ERCP) is recommended as first‐line therapy for biliary decompression in pancreatic cancer. The aim of our study was to characterize...

Full description

Bibliographic Details
Main Authors: Anna Tavakkoli, Amit G. Singal, Akbar K. Waljee, James M. Scheiman, Caitlin C. Murphy, Sandi L. Pruitt, Lei Xuan, Richard S. Kwon, Ryan J. Law, Grace H. Elta, Phyllis Wright‐Slaughter, Thomas S. Valley, Nisa Kubiliun, Hari Nathan, Joel H. Rubenstein, B. Joseph Elmunzer
Format: Article
Language:English
Published: Wiley 2019-07-01
Series:Cancer Medicine
Subjects:
disparities
ERCP
obstructive jaundice
pancreatic cancer
Online Access:https://doi.org/10.1002/cam4.2225

Internet

https://doi.org/10.1002/cam4.2225

Similar Items